Dr. Weeks’ Comment: All neurological illnesses and pathology are best conceptualized as diseases of toxic oils polluting the fatty acids of the nerves. So if you have MS or Parkinson’s or epilepsy or Chronic Fatigue or Lyme or tremors, you need to – literally – change your oil! Good oil in kicks bad oil out. What oil do you put in? Unadulterated omega 6 fatty acids. Organic and non-GMO seeds oils. AVOID the hydrogenated processed preservative vegetable oils (Canola, Soy, Corn etc) and eat things like black cumin seeds (the active ingredient of which, thymoquinone) is a neuroprotective agent.
Review Biochemistry (Mosc) . 2020 Feb;85(2):167-176. doi: 10.1134/S0006297920020042.
Thymoquinone as a Potential Neuroprotector in Acute and Chronic Forms of Cerebral Pathology
- PMID: 32093593
- DOI: 10.1134/S0006297920020042
Thymoquinone is one of the main active components of the essential oil from black cumin (Nigella sativa) seeds. Thymoquinone exhibits a wide range of pharmacological activities, including neuroprotective action demonstrated in the models of brain ischemia/reperfusion, Alzheimer’s and Parkinson’s diseases, and traumatic brain injury. The neuroprotective effect of thymoquinone is mediated via inhibition of lipid peroxidation, downregulation of proinflammatory cytokines, maintenance of mitochondrial membrane potential, and prevention of apoptosis through inhibition of caspases-3, -8, and -9. Thymoquinone-based mitochondria-targeted antioxidants are accumulated in the mitochondria and exhibit neuroprotective properties in nanomolar concentrations. Thymoquinone reduces the negative effects of acute and chronic forms of brain pathologies. The mechanisms of the pharmacological action of thymoquinone and its chemical derivatives require more comprehensive studying. In this paper, we formulated the prospects of application of thymoquinone and thymoquinone-based drugs in the therapy of neurodegenerative diseases.
- Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus.Al-Majed AA, Al-Omar FA, Nagi MN.Eur J Pharmacol. 2006 Aug 14;543(1-3):40-7. doi: 10.1016/j.ejphar.2006.05.046. Epub 2006 Jun 3.PMID: 16828080
- A Review on Possible Therapeutic Effect of Nigella sativa and Thymoquinone in Neurodegenerative Diseases.Samarghandian S, Farkhondeh T, Samini F.CNS Neurol Disord Drug Targets. 2018;17(6):412-420. doi: 10.2174/1871527317666180702101455.PMID: 29962349 Review.
- Neuroprotective Effects of Mitochondria-Targeted Plastoquinone and Thymoquinone in a Rat Model of Brain Ischemia/Reperfusion Injury.Silachev DN, Plotnikov EY, Zorova LD, Pevzner IB, Sumbatyan NV, Korshunova GA, Gulyaev MV, Pirogov YA, Skulachev VP, Zorov DB.Molecules. 2015 Aug 11;20(8):14487-503. doi: 10.3390/molecules200814487.PMID: 26270657 Free PMC article.
- Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis.Gökce EC, Kahveci R, Gökce A, Cemil B, Aksoy N, Sargon MF, Kısa Ü, Erdoğan B, Güvenç Y, Alagöz F, Kahveci O.J Neurosurg Spine. 2016 Jun;24(6):949-59. doi: 10.3171/2015.10.SPINE15612. Epub 2016 Feb 12.PMID: 26871652
- Thymoquinone: An edible redox-active quinone for the pharmacotherapy of neurodegenerative conditions and glial brain tumors. A short review.Elmaci I, Altinoz MA.Biomed Pharmacother. 2016 Oct;83:635-640. doi: 10.1016/j.biopha.2016.07.018. Epub 2016 Jul 25.PMID: 27459120 Review.